Health, News
Immuno-oncology: public research, private profits
New drugs are already revolutionising cancer treatments, improving patients’ life expectancy. A study by the European Patent Office showed that around 50% of applications were developed by universities and public bodies. But meanwhile, the cost of drugs continues to rise